Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2010 1
2013 1
2014 1
2015 1
2016 1
2017 2
2019 3
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia.
Soff GA, Miao Y, Bendheim G, Batista J, Mones JV, Parameswaran R, Wilkins CR, Devlin SM, Abou-Alfa GK, Cercek A, Kemeny NE, Sarasohn DM, Mantha S. Soff GA, et al. Among authors: sarasohn dm. J Clin Oncol. 2019 Nov 1;37(31):2892-2898. doi: 10.1200/JCO.18.01931. Epub 2019 Sep 23. J Clin Oncol. 2019. PMID: 31545663 Free PMC article. Clinical Trial.
Is It Time to Centralize Ovarian Cancer Care in the United States?
Cowan RA, O'Cearbhaill RE, Gardner GJ, Levine DA, Roche KL, Sonoda Y, Zivanovic O, Tew WP, Sala E, Lakhman Y, Vargas Alvarez HA, Sarasohn DM, Mironov S, Abu-Rustum NR, Chi DS. Cowan RA, et al. Among authors: sarasohn dm. Ann Surg Oncol. 2016 Mar;23(3):989-93. doi: 10.1245/s10434-015-4938-9. Epub 2015 Oct 28. Ann Surg Oncol. 2016. PMID: 26511267 Free PMC article. Review.
Limitations of CT during PET/CT.
Gollub MJ, Hong R, Sarasohn DM, Akhurst T. Gollub MJ, et al. Among authors: sarasohn dm. J Nucl Med. 2007 Oct;48(10):1583-91. doi: 10.2967/jnumed.107.043109. Epub 2007 Sep 14. J Nucl Med. 2007. PMID: 17873133 Free article.
Rivaroxaban treatment of cancer-associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience.
Soff GA, Mones J, Wilkins C, Devlin S, Haegler-Laube E, Wills J, Sarasohn DM, Juluru K, Singer M, Miao Y, Batista J, Mantha S. Soff GA, et al. Among authors: sarasohn dm. Res Pract Thromb Haemost. 2019 May 24;3(3):349-356. doi: 10.1002/rth2.12215. eCollection 2019 Jul. Res Pract Thromb Haemost. 2019. PMID: 31294321 Free PMC article.
A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer.
Cadoo KA, Grisham RN, O'Cearbhaill RE, Boucicaut NN, Henson M, Iasonos A, Zhou Q, Sarasohn DM, Gallagher J, Kravetz S, Zamarin D, Makker V, Sabbatini PJ, Tew WP, Aghajanian C, Konner JA. Cadoo KA, et al. Among authors: sarasohn dm. Gynecol Oncol. 2020 Apr;157(1):214-221. doi: 10.1016/j.ygyno.2020.01.018. Epub 2020 Jan 17. Gynecol Oncol. 2020. PMID: 31959492 Free PMC article. Clinical Trial.
A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative.
Straubhar AM, Filippova OT, Cowan RA, Lakhman Y, Sarasohn DM, Nikolovski I, Torrisi JM, Ma W, Abu-Rustum NR, Gardner GJ, Sonoda Y, Zivanovic O, Chi DS, Long Roche K. Straubhar AM, et al. Among authors: sarasohn dm. Gynecol Oncol. 2020 Sep;158(3):608-613. doi: 10.1016/j.ygyno.2020.05.041. Epub 2020 Jun 6. Gynecol Oncol. 2020. PMID: 32518012 Free PMC article.
Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease.
Kumar A, Sheedy S, Kim B, Suidan R, Sarasohn DM, Nikolovski I, Lakhman Y, McGree ME, Weaver AL, Chi D, Cliby WA. Kumar A, et al. Among authors: sarasohn dm. Gynecol Oncol. 2019 Jul;154(1):72-76. doi: 10.1016/j.ygyno.2019.04.011. Epub 2019 Apr 16. Gynecol Oncol. 2019. PMID: 31000471 Free PMC article.
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.
Suidan RS, Ramirez PT, Sarasohn DM, Teitcher JB, Iyer RB, Zhou Q, Iasonos A, Denesopolis J, Zivanovic O, Long Roche KC, Sonoda Y, Coleman RL, Abu-Rustum NR, Hricak H, Chi DS. Suidan RS, et al. Among authors: sarasohn dm. Gynecol Oncol. 2017 Apr;145(1):27-31. doi: 10.1016/j.ygyno.2017.02.020. Epub 2017 Feb 14. Gynecol Oncol. 2017. PMID: 28209497 Free PMC article.
14 results